Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine

Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine

Breast cancer is the second leading cause of morbidity and mortality in women worldwide. Despite advancements in the clinical application of neoadjuvant chemotherapy (NAC), drug resistance remains a major concern hindering treatment efficacy. Thus, identifying the key genes involved in driving NAC r...

Full description

Bibliographic Details
Main Authors: Trishna Saha Detroja, Rajesh Detroja, Sumit Mukherjee, Abraham O. Samson
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
breast cancer
neoadjuvant chemotherapy (NAC) resistance
co-expression
drug repurposing
precision medicine
Online Access:https://www.mdpi.com/1422-0067/23/20/12628

Internet

https://www.mdpi.com/1422-0067/23/20/12628

Similar Items